The Therapeutic Effect of Recombinant Human Epidermal Growth Factor (rhEGF) on Mucositis in Patients with Head and Neck Cancer Undergoing Radiotherapy with or without Chemotherapy: A Double-blind Placebo-controlled Prospective Phase II Multi-Institutional Clinical Trial